Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

UnitedHealth Edges Down After Fresh Guidance Partly Mitigates Profit Drop

Stock MarketsJul 15, 2021 07:27AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters.

By Dhirendra Tripathi

Investing.com – UnitedHealth (NYSE:UNH) stock was down 0.3% in premarket Thursday, giving up earlier gains of more than 1%, after the U.S.'s largest hospital operator confirmed a slump in profit in the second quarter.

Earnings per share fell to $4.70 from $7.12 a year earlier, when the cancellation of non-emergency surgeries due to Covid-19 kept its medical expenses exceptionally low. 

The number was still ahead of expectations and the company raised its full-year adjusted earnings outlook to $18.30-$18.80 per share. Revenue grew nearly 15% to $71.3 billion, some 4% ahead of forecasts. UnitedHealth expects revenue to stay buoyant as it works through the backlog of postponed procedures.

The company said COVID-19 effects where its services are needed include testing and treatment costs; the residual impact of people having deferred care in 2020; and unemployment and other economy-driven factors. 

The U.S. has vaccinated more than half its population with at least one dose of the vaccine but hesitancy among those not vaccinated and the rapid spread of Delta variant of the virus are now slowing the progress made earlier.

 

 

UnitedHealth Edges Down After Fresh Guidance Partly Mitigates Profit Drop
 

Related Articles

Novartis buys gene therapy company Arctos Medical
Novartis buys gene therapy company Arctos Medical By Reuters - Sep 21, 2021

ZURICH (Reuters) - Novartis has bought gene therapy specialist Arctos Medical to boost its efforts finding treatments for patients with severe vision loss, the Swiss company said...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (1)
Jose Tavares
Jose Tavares Jul 15, 2021 8:20AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Because of Medical Expenses were kept low, Earnings per share fell quite a drop a year earlier. USD revenue grew nearly at 15 percent, an Delta Variant Virus has slow down the majorityProgress that was made in the first half of the year.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email